We are live on ! Find out more

2,990 hedge funds and large institutions have $163B invested in Merck in 2022 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 1,374 increasing their positions, 1,114 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $2.42B | Put options by funds: $1.79B

23% more repeat investments, than reductions

Existing positions increased: 1,374 | Existing positions reduced: 1,114

16% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 104

0.78% more ownership

Funds ownership: 74.29%75.08% (+0.78%)

1% less funds holding

Funds holding: 3,0142,990 (-24)

4% less capital invested

Capital invested by funds: $171B → $163B (-$7.45B)

6% less funds holding in top 10

Funds holding in top 10: 238224 (-14)

Holders
2,990
Holders Change
-24
Holders Change %
-0.8%
% of All Funds
51.5%
Holding in Top 10
224
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.88%
% of All Funds
3.86%
New
121
Increased
1,374
Reduced
1,114
Closed
104
Calls
$2.42B
Puts
$1.79B
Net Calls
+$627M
Net Calls Change
+$85.4M
Name Holding Trade Value Shares
Change
Change in
Stake
TIM
1326
Tevis Investment Management
Texas
$2.3M +$27.7K +310 +1%
ZCA
1327
Zeke Capital Advisors
Pennsylvania
$2.29M -$357 -4 -0%
OIM
1328
Orca Investment Management
Oregon
$2.29M
PFM
1329
Patton Fund Management
Texas
$2.28M -$90.9K -1,018 -4%
VNA
1330
Valley National Advisers
Pennsylvania
$2.28M -$84.5K -947 -4%
CW
1331
CreativeOne Wealth
Kansas
$2.28M +$930K +10,418 +65%
LIA
1332
LS Investment Advisors
Michigan
$2.28M +$446 +5 +0%
BHB
1333
Bank Hapoalim BM
Israel
$2.28M
WSC
1334
Wellington Shields & Co
New York
$2.27M +$35.7K +400 +2%
TF
1335
Trek Financial
Arizona
$2.27M +$2.08M +23,347 +778%
PAM
1336
Palisade Asset Management
Minnesota
$2.27M +$35.3K +395 +2%
DMC
1337
Drexel Morgan & Co
Pennsylvania
$2.25M +$44.6K +500 +2%
HCM
1338
Hodges Capital Management
Texas
$2.24M -$1.35M -15,070 -37%
LC
1339
Legacy CG
Texas
$2.24M +$451K +5,053 +24%
BCP
1340
Blue Chip Partners
Michigan
$2.23M +$16.8K +188 +0.7%
WAM
1341
Werlinich Asset Management
Connecticut
$2.23M
ACM
1342
AlphaCrest Capital Management
New York
$2.22M +$2.3M +25,778 New
CGL
1343
Clarius Group LLC
Washington
$2.21M +$175K +1,956 +8%
4WM
1344
44 Wealth Management
Oregon
$2.21M +$305K +3,414 +15%
WB
1345
Webster Bank
Connecticut
$2.2M -$62.2K -697 -3%
KFGK
1346
Keystone Financial Group (Kentucky)
Kentucky
$2.19M +$56.5K +633 +3%
SGCA
1347
Steel Grove Capital Advisors
Tennessee
$2.18M -$52.6K -589 -2%
NLP
1348
Next Level Private
New York
$2.18M +$1.67M +18,759 +316%
IFG
1349
Independent Financial Group
California
$2.18M -$139K -1,555 -6%
KFI
1350
Key Financial Inc
Pennsylvania
$2.18M +$244K +2,730 +12%

MRK Hedge Fund Activity: Q3 2022 in Review

2,990 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2022, worth a combined $163B — down 4.4% from $171B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new MRK positions and 104 closed out — a net gain of 17 holders — while 1,374 added to existing stakes and 1,114 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $1.47B. The largest seller was Marshall Wace, cutting an estimated $459M.

  • 2,990 institutional investors held Merck (MRK) as of Q3 2022, down from 3,014 in Q2 2022.
  • Funds reported $163B of Merck stock for Q3 2022, down 4.4% quarter-over-quarter.
  • 121 funds opened new Merck positions in Q3 2022 and 104 closed out, a net change of +17 holders.
  • The largest Merck buyer in Q3 2022 was Janus Henderson Group, an estimated $1.47B added.
  • The largest Merck seller in Q3 2022 was Marshall Wace, an estimated $459M sold.

Based on aggregated 13F filings for Q3 2022.